A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy.

By J. McKiernan, M. Donovan, V. O'Neill, S. Bentink, M. Noerholm, S. Belzer, J. Skog, M. Kattan, Alan W. Partin, G. Andriole and 4 more. JAMA Oncology, 2016

625 citations recorded by the source corpus.

Subfields: Molecular Biology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/01dc61c92eec901d98f30b7f44d0f06a0e50f676

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Carlotta Pucci
2. Gianni Ciofani
3. C. Martinelli

Citations in the corpus

• Exosomes as a new frontier of cancer liquid biopsy (2022, methodology): “Based on the detection of ERG, PCA3, and SPDEF RNA in exosomes, EPI provides a risk score to predict whether a patient with PSA from 2 to 10 ng/mL is likely to develop higher-grade prostate cancer [214].”
• Innovative approaches for cancer treatment: current perspectives and new challenges (2019, methodology): “Gene expression profiling of multiple RNAs from urinary exosomes has been adopted as an efficient diagnostic tool [72].”